Viewing Study NCT06642558


Ignite Creation Date: 2025-12-25 @ 12:08 AM
Ignite Modification Date: 2025-12-29 @ 4:47 PM
Study NCT ID: NCT06642558
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-06-06
First Post: 2024-10-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Healthy Subjects Aged 18 Years and Above
Sponsor: MAXVAX Biotechnology Limited Liability Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module